The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 8
  • 1
    Gladstone, Michael
    Venture Capitalist born in October 1986
    Individual (2 offsprings)
    Officer
    2022-03-14 ~ now
    OF - director → CIF 0
  • 2
    Mozayeni, Cyrus
    Ceo born in July 1974
    Individual (1 offspring)
    Officer
    2023-07-10 ~ now
    OF - director → CIF 0
  • 3
    Chester, Cariad
    Venture Capital Investor born in July 1991
    Individual (2 offsprings)
    Officer
    2024-04-29 ~ now
    OF - director → CIF 0
  • 4
    Kirkpatrick, Shaun
    Venture Capital Investor born in November 1968
    Individual (2 offsprings)
    Officer
    2015-09-18 ~ now
    OF - director → CIF 0
  • 5
    Tobin, Jonathan Leslie
    Venture Capitalist born in December 1982
    Individual (6 offsprings)
    Officer
    2022-03-14 ~ now
    OF - director → CIF 0
  • 6
    Albers, Jeffery
    Director born in July 1971
    Individual (1 offspring)
    Officer
    2023-01-01 ~ now
    OF - director → CIF 0
  • 7
    Rooswinkel, Rogier Wouter, Dr
    Venture Capitalist born in August 1983
    Individual (3 offsprings)
    Officer
    2022-03-14 ~ now
    OF - director → CIF 0
  • 8
    Kariuki, Enoch
    Biotech Executive And Advisor born in December 1981
    Individual (1 offspring)
    Officer
    2024-09-04 ~ now
    OF - director → CIF 0
Ceased 5
  • 1
    Damour, Bertrand
    Chief Executive Officer born in March 1957
    Individual
    Officer
    2022-05-05 ~ 2023-07-10
    OF - director → CIF 0
  • 2
    Thurston, David Edwin, Professor
    Professor Of Drug Discovery born in May 1955
    Individual (6 offsprings)
    Officer
    2015-07-08 ~ 2022-03-14
    OF - director → CIF 0
  • 3
    Garrison, Michael Howard
    Company Director born in February 1957
    Individual
    Officer
    2020-04-09 ~ 2022-03-14
    OF - director → CIF 0
  • 4
    Keightley, Christopher Alan, Dr
    Company Director / Biochemist born in May 1954
    Individual (4 offsprings)
    Officer
    2015-09-18 ~ 2022-03-14
    OF - director → CIF 0
  • 5
    Brennan, Keith Gerard
    Company Director born in July 1968
    Individual (1 offspring)
    Officer
    2015-09-18 ~ 2020-04-09
    OF - director → CIF 0
parent relation
Company in focus

PHEON THERAPEUTICS LTD

Previous name
FEMTOGENIX LTD - 2022-08-03
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
92023-04-01 ~ 2024-03-31
92022-04-01 ~ 2023-03-31
Property, Plant & Equipment
961 GBP2024-03-31
20,043 GBP2023-03-31
Fixed Assets
961 GBP2024-03-31
20,043 GBP2023-03-31
Debtors
Current
2,311,584 GBP2024-03-31
2,486,182 GBP2023-03-31
Cash at bank and in hand
16,769,985 GBP2024-03-31
13,389,911 GBP2023-03-31
Current Assets
19,081,569 GBP2024-03-31
15,876,093 GBP2023-03-31
Creditors
Current, Amounts falling due within one year
-1,612,441 GBP2024-03-31
-1,833,112 GBP2023-03-31
Net Current Assets/Liabilities
17,469,128 GBP2024-03-31
14,042,981 GBP2023-03-31
Total Assets Less Current Liabilities
17,470,089 GBP2024-03-31
14,063,024 GBP2023-03-31
Net Assets/Liabilities
17,470,089 GBP2024-03-31
14,063,024 GBP2023-03-31
Equity
Called up share capital
3,686 GBP2024-03-31
2,096 GBP2023-03-31
Share premium
56,457,832 GBP2024-03-31
32,152,569 GBP2023-03-31
Retained earnings (accumulated losses)
-38,991,429 GBP2024-03-31
-18,091,641 GBP2023-03-31
Equity
17,470,089 GBP2024-03-31
14,063,024 GBP2023-03-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
39,627 GBP2024-03-31
353,616 GBP2023-03-31
Property, Plant & Equipment - Gross Cost
47,276 GBP2024-03-31
361,495 GBP2023-03-31
Property, Plant & Equipment - Other Disposals
Plant and equipment
-313,989 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Other Disposals
-314,219 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Plant and equipment
334,724 GBP2023-03-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
341,451 GBP2023-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment, Owned/Freehold
6,196 GBP2023-04-01 ~ 2024-03-31
Owned/Freehold
7,932 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
Plant and equipment
-301,579 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
-303,068 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
39,341 GBP2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
46,315 GBP2024-03-31
Property, Plant & Equipment
Plant and equipment
286 GBP2024-03-31
18,891 GBP2023-03-31
Trade Debtors/Trade Receivables
Current
35,000 GBP2023-03-31
Amounts Owed by Group Undertakings
Current
44,733 GBP2023-03-31
Other Debtors
Current
2,084,076 GBP2024-03-31
1,934,669 GBP2023-03-31
Prepayments/Accrued Income
Current
227,508 GBP2024-03-31
471,780 GBP2023-03-31
Trade Creditors/Trade Payables
Current
710,500 GBP2024-03-31
924,318 GBP2023-03-31
Amounts owed to group undertakings
Current
179,082 GBP2024-03-31
Taxation/Social Security Payable
Current
6,020 GBP2024-03-31
Other Creditors
Current
6,514 GBP2024-03-31
998 GBP2023-03-31
Accrued Liabilities/Deferred Income
Current
710,325 GBP2024-03-31
907,796 GBP2023-03-31
Creditors
Current
1,612,441 GBP2024-03-31
1,833,112 GBP2023-03-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
5,188,168 shares2024-03-31
1,821,341 shares2023-03-31
Class 2 ordinary share
3,800,000 shares2024-03-31
3,800,000 shares2023-03-31
Class 3 ordinary share
27,866,719 shares2024-03-31
15,343,629 shares2023-03-31
  • PHEON THERAPEUTICS LTD
    Info
    FEMTOGENIX LTD - 2022-08-03
    Registered number 09677410
    Innovation House Innovation Way, Discovery Park, Sandwich, Kent CT13 9FF
    Private Limited Company incorporated on 2015-07-08 (9 years 11 months). The company status is Active.
    The last date of confirmation statement was made at 2024-10-19
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy policy

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.